CCR Monthly Approval Report – October 2022

A total of 35 products were added in the month from seven different asset managers: Aegon, Allianz, BNP Paribas, The Colchester, Bridge, Driftwood and Vitruvian.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – September 2022

UBS, Altor and Cortland were the fund sponsors gaining approval for new products in September.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – August 2022

A total of 15 products were added in the month from six different brands: Actis, Amundi, Brookfield, Global X, M&G, and Mirae.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – June 2022

A total of nine products were added in the month from five different asset managers: Fidelity, DWS, Fullerton, Liontrust, PineBridge and Exeter Property Group.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – July 2022

A total of 34 products were added in the month from eight different asset managers: Eaton Vance, GAM, Greystar, Invesco, Jupiter, Manulife, PIMCO and UBS.

This content is reserved for our licensees.

Log In Register

CCR suspends some Allianz funds in Chile on heels of SEC charges

Market actors said they did not see fraud charges in the US impacting the firm's success in Chile.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – May 2022

T. Rowe Price led with nine products registered, while Credicorp Capital, Eastspring, Invesco, Silver Lake and Veritas Capital completed the list. each with one product approved.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – April 2022

BlackRock and Lazard led, both with three mutual funds approved in the month, while Jupiter, UBS and State Street with one product each completed the list.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – March 2022

Nordea lead with four equity funds approved, followed by Bci, Candriam, JSS, Schroders, Vontobel and Arcano with one product each.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – February 2022

A total of 15 products were added in the month from four different asset managers: iShares, Allianz, M&G and Vanguard.

This content is reserved for our licensees.

Log In Register